ACADIA Pharmaceuticals is committed to improving the lives of its patients by dedicating its resources to the advancement of medicine for central nervous system (CNS) disorders. Founded in 1993 as Receptor Technologies by Mark Brann, PhD, the company operates from its headquarters in San Diego, California, and maintains a research and development center in Princeton, New Jersey. As an employer, ACADIA takes pride in offering its professionals a stimulating work environment, an opportunity to make a positive impact, competitive compensation, attractive benefit packages, and more as eligible. The company values work-life balance by offering paid vacation and holidays, paid sick time, and programs for education assistance, health advocacy, and beyond. ACADIA has also provided flexible job options, such as temporary jobs, in medical & health and other fields.

Made up of talented and experienced people dedicated to making a positive impact on patients, caregivers, and the healthcare community, ACADIA is proud of its roots in science and leadership in CNS research. The biopharmaceutical company produced NUPLAZID, the first and only medication approved by the FDA for treatment of Parkinson’s disease psychosis symptoms, such as delusions and hallucinations. The drug, Pimavanserin, is produced under the NUPLAZID name and also works to alleviate symptoms associated with dementia-related psychosis, schizophrenia, major depressive disorder, and more. In 2016, ACADIA was awarded the California Life Sciences Association’s Pantheon DiNA Award for Outstanding Therapeutic Product for NUPLAZID (pimavanserin). The company also works to serve its community through the ACADIA Cares program.

ACADIA Pharmaceuticals is committed to improving the lives of its patients by dedicating its resources to the advancement of medicine for central nervous system (CNS) disorders. Founded in 1993 as Receptor Technologies by Mark Brann, PhD, the company operates from its headquarters in San Diego, California, and maintains a research and development center in Princeton, New Jersey. As an employer, ACADIA takes pride in offering its professionals a stimulating work environment, an opportunity to make a positive impact, competitive compensation, attractive benefit packages, and more as eligible. The company values work-life balance by offering paid vacation and holidays, paid sick time, and programs for education assistance, health advocacy, and beyond. ACADIA has also provided flexible job options, such as temporary jobs, in medical & health and other fields.

Made up of talented and experienced people dedicated to making a positive impact on patients, caregivers, and the healthcare community, ACADIA is proud of its roots in science and leadership in CNS research. The biopharmaceutical company produced NUPLAZID, the first and only medication approved by the FDA for treatment of Parkinson’s disease psychosis symptoms, such as delusions and hallucinations. The drug, Pimavanserin, is produced under the NUPLAZID name and also works to alleviate symptoms associated with dementia-related psychosis, schizophrenia, major depressive disorder, and more. In 2016, ACADIA was awarded the California Life Sciences Association’s Pantheon DiNA Award for Outstanding Therapeutic Product for NUPLAZID (pimavanserin). The company also works to serve its community through the ACADIA Cares program.